Liquid chromatographic–mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics
- 9 March 2001
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 753 (2) , 401-408
- https://doi.org/10.1016/s0378-4347(00)00574-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A validated LC method for the quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugsJournal of Pharmaceutical and Biomedical Analysis, 2000
- CelecoxibDrugs, 2000
- Clinical Pharmacokinetics and Pharmacodynamics of CelecoxibClinical Pharmacokinetics, 2000
- Celecoxib-Induced Acute Pancreatitis and Hepatitis: A Case ReportArchives of internal medicine (1960), 2000
- Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled TrialThe Journal of Clinical Pharmacology, 2000
- Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase -2–selective inhibitionThe American Journal of Medicine, 1999